TipRanks
Go Ultimate55% OFF

Christopher Senner Insider Profile

11 Followers

Christopher Senner, Director at IRulya Therapeutics, holds ― shares in IRulya Therapeutics (Ticker: IRLA), holds 955.04K shares in Exelixis (Ticker: EXEL).

Christopher Senner's Trading History

EXEL
Exelixis
May 19, 2026EVP & CFOInformative Sell3.83M$66.27M
IRLA
IRulya Therapeutics
―Director――

You May Also Like

Christopher Senner insider profile FAQ

What is the percentage of profitable transactions made by Christopher Senner?
The percentage of profitable transactions made by Christopher Senner is 33%.
What is the average return per transaction made by Christopher Senner?
The average return per transaction made by Christopher Senner is -15.30%.
What stocks does Christopher Senner hold?
Christopher Senner holds: IRLA, EXEL stocks.
What was Christopher Senner's most profitable transaction?
Christopher Senner’s most profitable transaction was an Informative Sell of EXEL stock on September 14, 2017. The return on the trade was 37.70%.
What is Christopher Senner's role in IRulya Therapeutics?
Christopher Senner's role in IRulya Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.